Introduction: Periodontitis affects more than 20% of the Latin American population.Oxidative markers are associated with greater progression of periodontitis; therefore, its role in pathogenesis should be studied.Objective: To determine the prevalence of the main oral bacteria and viruses associated with periodontitis and estimate the total antioxidant capacity and lipid peroxidation in saliva from patients with periodontitis.Materials and methods: We conducted systemically a cross-sectional study in 101 healthy subjects, 87 of whom had been diagnosed with periodontitis (P), according to the criteria of the Centers of Disease Control and Prevention and the American Academy of Periodontology, and 14 without periodontal pockets as controls (C). In subgingival samples, major viruses and dental pathogenic bacteria were identified using PCR techniques. The levels of total antioxidant capacity and malon-di-aldehyde (MDA) were determined by spectrophotometry in samples of unstimulated saliva.Results: The mean of periodontal depth pocket and clinical attachment loss in patients with periodontitis was 5.6 ± 1.7 and 6.1 ± 3.1 mm, respectively. The most prevalent microorganisms were Aggregatibacter actinomycetemcomitans (32.5%) and Porphyromonas gingivalis (18.6%). The patients from rural areas showed a higher percentage of A. actinomycetemcomitans (urban: 17.9% vs. rural: 48.9%, p=0.0018). In patients with periodontitis, the frequency of EBV, HSV1 & 2, and HCMV genes was 2.3%. Periodontitis patients had higher levels of MDA (P: 2.1 ± 1.5; C: 0.46 ± 0.3 μmol/g protein; p=0.0001) and total antioxidant capacity (P: 0.32 ± 0.2; C: 0.15 ± 0.1 mM; p< 0.0036). Oxidative markers showed no modifications due to the presence of periodontopathic bacteria.Conclusions: Aggregatibacter actinomycetemcomitans was the most prevalent bacteria; its presence did not modify the levels of oxidative markers in the saliva of patients with periodontitis.

No abstract

No abstract

Objetivo: Determinar la resistencia a antimicrobianos de uropatógenos aislados de pacientes ambulatorios atendidos en el Laboratorio Clínico de Especialidades Bolívar S.A. de Bucaramanga, Santander. Metodología: Se realizó un estudio descriptivo retrospectivo (de Enero a Julio de 2009) a 1394 pacientes ambulatorios atendidos en el Laboratorio Clínico de Especialidades Bolívar S.A. de Bucaramanga Santander, con evidencia clínica o no de infecciones de tracto urinario (ITU) y orden médica de Gram, urocultivo y antibiograma. Resultados: De los 1394 urocultivos realizados, se obtuvieron 589 pacientes con urocultivos positivos (42,3%); la mayoría correspondieron a uropatógenos Gram negativos; donde Eschericha coli fue el microorganismo más frecuente. Con respecto a los agentes utilizados en el tratamiento, el perfil de susceptibilidad encontrado para Eschericha coli como para otros microorganismos, mostró elevadas tasas de resistencia para Amoxacilina (59,1%), Ácido Nalidixico (52,1%), Cotrimoxazol (42,2%) y Ciprofloxacina (40,7%). Las tasas de resistencia más bajas se observaron para antibióticos como Imipinem (0,8%) y Fosfomicina (3,1%). Conclusiones: Eschericha coli sigue siendo el microorganismo más frecuentemente aislado a nivel mundial y el que ha presentado en los últimos años mayor resistencia a antibióticos. Con respecto al género más afectado el femenino sigue siendo el más vulnerable para estas infecciones por presentar mayores factores de riesgo.

Background: Metachromatic leukodystrophy (MLD) is a neurological lysosomal deposit disease that has an impact on public health despite its low incidence in the population. Existing treatments are expensive and inefficient. Few reports in the literature on pathophysiological events related to enzyme deficiency and subsequent accumulation of sulfatides; therefore, the use of metformin as an alternative treatment was evaluated in vitro to counteract the effects. Methodology: An experimental in vitro study that sought to determine the effect of the use of metformin on the accumulation of sulfates in glycolysis and mitochondrial function in an in vitro model of metachromatic leukodystrophy. Human Schwann cells (CSH) transfected with CRISPR Cas9 and without transfection were treated with different concentrations of sulfatides and metformin. Cell viability was evaluated by MTT and SYTOX Green; mitochondrial and glycolytic function by Seahorse XFe24, determination of reactive oxygen species (ROS) and cell death. Results: In the MTT trials, we found that treatment with different concentrations of sulfates did not affect cell viability. Transfected CSH showed higher cell death and ROS production when exposed to 100 µM sulfatides with a statistically significant difference (p <0.001), compared to nontransfected CSH cells. Sulfatides at concentrations of 10 to 100 µM affect mitochondrial bioenergetics as concentrations increase in transfected cells, in nontransfected cells they respond metabolically to exposure; Furthermore, transfected cells show a decrease in basal respiration and maximum respiration after being exposed to a concentration of 100 µM of sulphates; however, in double treatment of these cells with both sulfates and Metformin, respiration also decreases. Maximum and normal mitochondrial respiratory capacity. Conclusion: This research describes for the first time the generation of transfected CSH and the bioenergetic and mitochondrial effect of sulfates in Schwann cells, treatment with 500 µM of Metformin restores metabolic activity of these cells and decreases ROS production, as well as prevention of cell death.

No abstract

Este es un resúmen de acceso abierto (Open Access), distribuido bajo los términos de la licencia Creative Commons Attribution (CC BY 4.0), esta licencia permite a otros distribuir, mezclar, ajustar y construir a partir de esta obra, incluso con fines comerciales, siempre y cuando se adjudique el crédito al autor original y se cite este manuscrito como la fuente de la primera publicación del trabajo.

Metachromatic leukodystrophy is a neurological lysosomal deposit disease that affects public health despite its low incidence in the population. Currently, few reports are available on pathophysiological events related to enzyme deficiencies and subsequent sulfatide accumulation. This research aims to examine the use of metformin as an alternative treatment to counteract these effects. This was evaluated in human Schwann cells (HSCs) transfected or non-transfected with CRISPR-Cas9, and later treated with sulfatides and metformin. This resulted in transfected HSCs showing a significant increase in cell reactive oxygen species (ROS) production when exposed to 100 µM sulfatides ( p = 0.0007), compared to non-transfected HSCs. Sulfatides at concentrations of 10 to 100 µM affected mitochondrial bioenergetics in transfected HSCs. Moreover, these analyses showed that transfected cells showed a decrease in basal and maximal respiration rates after exposure to 100 µM sulfatide. However, maximal and normal mitochondrial respiratory capacity decreased in cells treated with both sulfatide and metformin. This study has provided valuable insights into bioenergetic and mitochondrial effects of sulfatides in HSCs for the first time. Treatment with metformin (500 µM) restored the metabolic activity of these cells and decreased ROS production.